KAREN NATSUHARA: Open Payments
NPI 1629194667 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $521 · 2025 $323
Food & beverage: $224Education: $99
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $126 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Janssen Biotech, Inc. | 1 | $42 |
| ARRAY BIOPHARMA INC | 1 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Trodelvy, OPDIVO, ERLEADA, BRAFTOVI, Onivyde, VERZENIO, LIBTAYO.
Industry payments across CA — which companies pay providers there.
